Source:http://linkedlifedata.com/resource/pubmed/id/14561170
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-10-16
|
pubmed:abstractText |
Asthma is characterized by elevated production of IgE, Th2 cytokines, chemokines, mucus hypersecretion, globlet cell metaplasia/hyperplasia, airway obstruction, eosinophilia and enhanced bronchial hyperresponsiveness. These hallmark features of asthma have all been linked to the effector functions of Th2 cytokines (e.g., interleukin-(IL)-4,5,9,10, and 13) in clinical and experimental investigations. This article will detail some of the pathogenic effects regulated by IL-13, IL-5 and the eotaxin subfamily of chemokines to regulate certain aspects of allergic disease. In particular, the potency of IL-13 in inducing enhanced bronchial responsiveness to spasmogenic stimuli and mucus hypersecretion suggests a key role of this molecule in the induction of airways obstruction. Recent studies also indicate that IL-5 and eotaxin, through eosinophils, may regulate Th2 cell function and IL-13 production from this lymphocyte. Therefore, IL-5 and IL-13 signaling systems are not necessarily mutually exclusive effector mechanisms, but may also be integrated through eosinophils to regulate certain aspects of allergic diseases. Blocking IL-13, or pathways that may promote IL-13-associated allergic lung responses (IL-5 and eotaxin) could provide an important strategy to improve the specificity of asthma therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCL11 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL11,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-13,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-5
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1568-010X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-74
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14561170-Animals,
pubmed-meshheading:14561170-Cell Movement,
pubmed-meshheading:14561170-Chemokine CCL11,
pubmed-meshheading:14561170-Chemokines, CC,
pubmed-meshheading:14561170-Eosinophils,
pubmed-meshheading:14561170-Humans,
pubmed-meshheading:14561170-Inflammation,
pubmed-meshheading:14561170-Interleukin-13,
pubmed-meshheading:14561170-Interleukin-5,
pubmed-meshheading:14561170-Th2 Cells
|
pubmed:year |
2003
|
pubmed:articleTitle |
Regulation of eosinophil migration and Th2 cell function by IL-5 and eotaxin.
|
pubmed:affiliation |
Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstr. 1, 79106 Freiburg, Germany. mattes@kkl200.ukl.uni-freiburg.de
|
pubmed:publicationType |
Journal Article,
Review
|